PRESS RELEASE published on 06/12/2025 at 18:00, 1 year 1 month ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
BRIEF published on 06/12/2025 at 08:35, 1 year 1 month ago Oxurion progresses in its acquisition of Axiodis Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE published on 06/12/2025 at 08:30, 1 year 1 month ago Oxurion moves forward with the planned acquisition of Axiodis Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
BRIEF published on 06/11/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/11/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF published on 06/04/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Legislation
PRESS RELEASE published on 06/04/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV has received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in shareholding, crossing under the 5% threshold Clinical Research Transparency Notification Biopharmaceutical Shareholding Change Oxurion NV
BRIEF published on 05/28/2025 at 18:05, 1 year 2 months ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Transparency Notification Biopharmaceutical Industry Voting Securities Oxurion Shares Atlas Holdings
PRESS RELEASE published on 05/28/2025 at 18:00, 1 year 2 months ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding shareholding thresholds pursuant to Belgian Transparency legislation Oxurion NV Shareholding Thresholds Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II LLC
BRIEF published on 05/22/2025 at 18:05, 1 year 2 months ago Results of the Oxurion General Meeting Securities Shareholders Forward-looking Statements General Assembly Oxurion
Published on 08/01/2026 at 01:20, 2 days 9 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 9 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 10 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 11 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 10:30, 15 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 08/03/2026 at 10:16, 29 minutes ago AUSTRIACARD HOLDINGS AG: Fulfilment of Condition Precedent regarding the Merger Control Clearance in relation to DNP’s Voluntary Takeover Offer
Published on 08/03/2026 at 09:18, 1 hour 26 minutes ago Conference call on the results for the 3rd quarter 2025/2026 (ending 30 June 2026) on 12 August 2026
Published on 08/03/2026 at 08:29, 2 hours 16 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 3 hours 45 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 13 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 15 hours ago Share retention commitments (Dutreil Agreement)
